Alterity Therapeutics Limited (ATHE)
ATHE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.85
-2.73% on the day
Market cap
$51.9M
Micro cap
Revenue
No annual revenue filed since the period ending 2018-06-30
Net income
No annual revenue filed since the period ending 2018-06-30
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ATHE on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Australia |
| IPO year | Not reported by the screener |
| SEC CIK | 0001131343 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | C3 |
Financials
No annual revenue filed since the period ending 2018-06-30.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2024-02-15 |
| Latest annual report FORM 20-F | 20-F | 2026-08-28 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-09 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RNXT | RenovoRx Inc. | $1.15 | -8.00% | $51.9M |
| HYPD | Hyperion DeFi Inc. | $3.36 | -3.17% | $51.9M |
| MREO | Mereo BioPharma Group plc | $0.3200 | +1.52% | $51.1M |
| IBIO | iBio Inc. | $0.7818 | -13.44% | $50.3M |
| ALDX | Aldeyra Therapeutics Inc. | $0.8998 | -0.66% | $54.3M |
| TLPH | Talphera Inc. | $1.07 | -0.93% | $55.5M |
| CLNN | Clene Inc. | $3.39 | -7.88% | $48.2M |
| HOWL | Werewolf Therapeutics Inc. | $0.9911 | +0.95% | $48.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier